Skip to main content

Waste Management

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Martin Pharmaceuticals
2 programs
Ad libitum data collectionN/A1 trial
Controlled ConditionsN/A1 trial
Active Trials
NCT06030687Completed25Est. Aug 2024
NCT06030700Completed25Est. Feb 2025

Trial Timeline

Clinical trial activity over time

2024
2025
2026
Martin PharmaceuticalsControlled Conditions
Martin PharmaceuticalsAd libitum data collection

Clinical Trials (2)

Total enrollment: 50 patients across 2 trials

FoodImage 3 Laboratory

Start: Jan 2024Est. completion: Feb 202525 patients
N/ACompleted
NCT06030687Martin PharmaceuticalsAd libitum data collection

FoodImage 3 Free-Living

Start: Jan 2024Est. completion: Aug 202425 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.